Biomaterial Database

[Termination of pregnancy with a mifepristone-sulprostone combination]. 1987

B Maria, and F Stampf

UI	MeSH Term	Description	Entries
D011247	Pregnancy	The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	Gestation,Pregnancies
D011459	Prostaglandins E, Synthetic	Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE.	PGE Synthetic,Prostaglandin E Analogs,Prostaglandin E Analogues,Synthetic Prostaglandins E,Analogs, Prostaglandin E,Analogues, Prostaglandin E,Synthetic, PGE
D004963	Estrenes	Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds.	19-Norandrostenes,19 Norandrostenes
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000019	Abortifacient Agents	Chemical substances that interrupt pregnancy after implantation.	Abortifacient Effect,Abortifacient Effects,Abortifacients,Contraceptive Agents, Postconception,Agents, Abortifacient,Agents, Postconception Contraceptive,Effect, Abortifacient,Effects, Abortifacient,Postconception Contraceptive Agents
D000020	Abortifacient Agents, Nonsteroidal	Non-steroidal chemical compounds with abortifacient activity.	Abortifacient Agents, Non-Steroidal,Abortifacient Agents, Non Steroidal,Agents, Non-Steroidal Abortifacient,Agents, Nonsteroidal Abortifacient,Non-Steroidal Abortifacient Agents,Nonsteroidal Abortifacient Agents
D000021	Abortifacient Agents, Steroidal	Steroidal compounds with abortifacient activity.	Steroid Abortifacients,Abortifacients, Steroid,Agents, Steroidal Abortifacient,Steroidal Abortifacient Agents
D000029	Abortion, Legal	Termination of pregnancy under conditions allowed under local laws. (POPLINE Thesaurus, 1991)	Abortion on Demand,Abortions, Legal,Legal Abortion,Legal Abortions
D015232	Dinoprostone	The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa.	PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2

Related Publications

B Maria, and F Stampf

Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).

January 1989, Acta obstetricia et gynecologica Scandinavica,

B Maria, and F Stampf

[Cardio-circulatory arrest with mifepristone sulprostone combination for pregnancy interruption].

January 1991, Therapie,

B Maria, and F Stampf

Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.

November 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,

B Maria, and F Stampf

Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.

February 1993, Contraception,

B Maria, and F Stampf

Termination of pregnancy with mifepristone.

September 1993, BMJ (Clinical research ed.),

B Maria, and F Stampf

Termination of normal and pathological pregnancy with Sulprostone.

January 1986, Acta chirurgica Hungarica,

B Maria, and F Stampf

The combination of mifepristone and misoprostol for the termination of pregnancy.

October 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,